Evidence map›Paper›PMID 32807918›Full record

ReviewNature materials2020

Applications and challenges of thermoplasmonics.

Guillaume Baffou, Frank Cichos, Romain Quidant

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature materials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Superlattice Architectures for Advancing Photothermal Catalysis: Mechanisms and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  10. Article
  11. Electrotunable Kapitza Resistance at Electrode-Water Interfaces: The Importance of Electrode Metallicity.The journal of physical chemistry. C, Nanomaterials and interfaces · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guillaume BaffouInstitut Fresnel, CNRS, Aix Marseille University, Ecole Centrale Marseille, Marseille, France. guillaume.baffou@fresnel.fr.ORCID http://orcid.org/0000-0003-0488-1362
Frank CichosMolecular Nanophotonics Group, Peter Debye Institute for Soft Matter Physics, Universität Leipzig, Leipzig, Germany. cichos@physik.uni-leipzig.de.ORCID http://orcid.org/0000-0002-9803-4975
Romain QuidantICFO - Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Barcelona, Spain. rquidant@ethz.ch.ORCID http://orcid.org/0000-0001-8995-8976

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past two decades, there has been a growing interest in the use of plasmonic nanoparticles as sources of heat remotely controlled by light, giving rise to the field of thermoplasmonics. The ability to release heat on the nanoscale has already impacted a broad range of research activities, from biomedicine to imaging and catalysis. Thermoplasmonics is now entering an important phase: some applications have engaged in an industrial stage, while others, originally full of promise, experience some difficulty in reaching their potential. Meanwhile, innovative fundamental areas of research are being developed. In this Review, we scrutinize the current research landscape in thermoplasmonics, with a specific focus on its applications and main challenges in many different fields of science, including nanomedicine, cell biology, photothermal and hot-electron chemistry, solar light harvesting, soft matter and nanofluidics.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.